Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Viralgen is a specialized contract development and manufacturing organization focused on adeno-associated virus (AAV)-based gene therapy manufacturing. The company provides end-to-end services spanning construct optimization, plasmid DNA production, process development, cGMP clinical manufacturing, and commercial-scale production for clients developing genetic medicines. Its core technology is the Aava manufacturing platform, built on the proprietary Pro10 cell line licensed from AskBio, and the company positions itself as an AAV-dedicated manufacturer rather than a therapeutic developer with its own drug pipeline. Viralgen operates as an independently run subsidiary of AskBio within the Bayer group and serves biotechnology, pharmaceutical, and rare-disease partners worldwide. The company is based in San Sebastian, Spain, and emphasizes large-scale, high-yield, scalable rAAV manufacturing across multiple serotypes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viral Vector Core.